Clinical Trial

Leverage Noninvasive Transcutaneous Vagus Nerve Stimulation to Reduce Suicidal Behaviors in Vulnerable Adolescents

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Suicidal thoughts, suicide attempts, and suicide are increasingly common in adolescence. Current face-to-face prevention approaches are of limited effectiveness, rely on extensive resources, and are at odds with adolescents' digital preferences. We will evaluate two unconventional but promising interventions delivered to 13- to 17-year-olds: transcutaneous vagus nerve stimulation to target emotion dysregulation, and a peer-support smartphone app to combat social isolation. If effective, these digitally-delivered interventions could reach far more adolescents at far lower cost than current approaches.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-11-01; most recent amendment 2026-04-15.
Status change: Recruiting → Active, Not Recruiting 2026-04-15
Status change: Not Yet Recruiting → Recruiting 2023-11-29
Trial Details
NCT Number NCT05602779
Lead Sponsor University of Notre Dame
Collaborators: University of Rochester, University of Wisconsin, Madison
Conditions Self Harm, Suicidal Ideation
Enrollment 200 participants
Start Date 2024-11-15
Primary Completion 2027-04-15 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-17